Results 121 to 130 of about 3,695 (214)

Representation of underserved communities in non-pharmacological axial spondyloarthritis trials: a scoping review protocol. [PDF]

Rheumatol Adv Pract
Mathew A, Prior Y, Buckley J, Loades J, Prior JA, Packham J, Battista S.   +6 more
europepmc   +1 more source

Fibrinogen-to-Platelet Ratio and Hematologic Inflammatory Indexes in Spondylarthritis. [PDF]

J Clin Med
Ungureanu RD, Bita CE, Voicu MN, Turcu-Stiolica A, Firulescu SC, Turcu-Stiolica M, Bărbulescu AL, Dinescu SC, Vreju FA.   +8 more
europepmc   +1 more source

Editorial: Understanding eQTLs and their Association with Spondyloarthropathies. [PDF]

Front Immunol
Vecellio M.
europepmc   +1 more source

A Review of the role of IL-23 within Axial Spondylarthritis and the hypothesized relationship with DTL in human patients

Axial spondylarthritis (AxSpA) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, with interleukin-23 (IL-23) identified as a pivotal driver of pathogenic T helper 17 (Th17) and type 3 innate lymphoid cell (ILC3 ...
Sadiku, Eric
core  

Comparative analysis of whole spine and sacroiliac joint magnetic resonance SPARCC scores in patients with SAPHO syndrome and ankylosing spondylitis. [PDF]

Front Immunol
Shen Y, Gu X, Yang J, Zhou M, Lin Z, Wang R, Liu J, Guo M, Li C, Zhu Q, He D.   +10 more
europepmc   +1 more source

Achilles Enthesitis in Psoriatic Arthritis: Inter-Observer Reliability of Ultrasound Findings. [PDF]

J Clin Med
Agache M, Enache L, Popescu CC, Dumitrescu B, Ionescu CE, Moscalu DE, Bobirca A, Codreanu C.   +7 more
europepmc   +1 more source

Men with psoriatic arthritis, rheumatoid arthritis and axial spondylarthritis have more children and at an earlier age than matched controls: results from a nationwide cohort. [PDF]

RMD Open
Sigmo GD, Hauge S, Hetland HB, Wallenius M, Lauvsnes MB, Salvesen KÅ, Daltveit AK, Bakland G, Fevang BS.   +8 more
europepmc   +1 more source

Assessing real-world treatment with SDZ ETN (an etanercept biosimilar) in people with rheumatic diseases included in the COMPACT study: a plain language summary. [PDF]

Immunotherapy
Schmalzing M, Kellner H, Askari A, de Toro Santos J, Perez-Coleman JCV, Foti R, Jeka S, Allanore Y, Peichl P, Oehri M, Betteridge N, Salvati C, Romero E, Brueckmann I, Sheeran T.   +14 more
europepmc   +1 more source

The role of interleukin-17 inhibition in systemic lupus erythematosus-paradoxical hindrance or new therapeutic potential? Results from a systematic literature review and mendelian randomization. [PDF]

Front Immunol
Nagra D, Zuckerman B, Odia J, Patel S, Ong M, Adas M, Yang Z, Bechman K, Russell M, Bhandari S, Rosa C, Banerjee S, Blake T, Gullick N, Kasavkar G, Wincup C.   +15 more
europepmc   +1 more source

[Psoriatic spondylarthritis or spondylarthritis in psoriasis?].

Reumatismo, 1969
M, Mellini, G, Secondo
openaire   +1 more source